Author: Mike Fazioli

This is a cash and stock transaction that values Penumbra at $374 per share. The move helps Boston Scientific expand its vascular and neurovascular portfolios, gaining new treatments for pulmonary embolism, stroke, deep vein thrombosis and many other critical cardiovascular conditions.Read More

Read More

Plan your Alaska adventure with our guide to the best times for bear spotting, park visits, and more. Discover the ideal seasons for travel deals and wildlife.Read More

Read More